Most of these expression changes can be ascribed to a reduction of Myc:Spt5 complexes, whereas some probably reflect a functional interaction of Spt5 with the Mediator complex, which itself plays a role in NB II tumor formation. The gene discussed is SUPT5H; the disease is neoplasm.